Skip to Content

Join the 'Chronic Granulomatous Disease' group to help and get support from people like you.

Chronic Granulomatous Disease News

First Drug, Nucala (Mepolizumab), Approved for Rare Eosinophilic Granulomatosis With Polyangiitis

Posted 12 Dec 2017 by

TUESDAY, Dec. 12, 2017 – Nucala (mepolizumab) has been approved by the U.S. Food and Drug Administration as the first remedy to treat adults with eosinophilic granulomatosis with polyangiitis, a rare autoimmune disease that leads to inflammation of the blood vessels. Other symptoms of the condition, formerly called Churg-Stress syndrome, include asthma and an overabundance of an ...

U.S. Researchers Find New Way to Gauge Rare Genetic Condition

Posted 29 Dec 2010 by

WEDNESDAY, Dec. 29 – Federal researchers say they've gained insight into how to analyze the risks facing people with a rare immune system-weakening condition called chronic granulomatous disease, paving the way toward more personalized treatment. "Advances in treatment of CGD have made it possible for people with this once-fatal disease of early childhood to survive into adulthood; however, the ...

Ask a Question

Further Information

Related Condition Support Groups


Related Drug Support Groups

interferon gamma-1b, Actimmune